STATEC up and running at trio of new sites in Europe

16 May 2019

A CTC trial investigating treatment for cancer of the womb has opened at three more study sites, this time in the Netherlands.

STATEC, which involves a comparison of two surgical techniques to determine ongoing treatment for endometrial cancer patients, has been open since 2017. Already running at hospitals in the UK, Australia and New Zealand, the study now adds Haaglanden Medical Centre, Catharina Ziekenhuis and Zuyderland to its list of recruiting centres.

STATEC continues to recruit patients internationally. For more information on the trial, visit its page on the CTC website.

More news articles

Cervical Cancer Prevention Week in the UK

This week (22 January - 28 January) marks Cervical Cancer Prevention Week in the United Kingdom. Launched by Jo's Cervical Cancer Trust, the [...]

MCARTY presented at ASH conference in California

A CTC study of CAR T cell therapy for patients with multiple myeloma presented its findings at a conference in the United States last week.M [...]

Lung Cancer Awareness Month

November marks Lung Cancer Awareness Month, an annual initiative aimed at raising public awareness of the third most common type of cancer i [...]

CTC study findings hailed as 'biggest cervical cancer breakthrough in 20 years'

Trial results presented by researchers from UCL and UCLH have shown a course of treatment with existing drugs prior to chemoradiation led to [...]

Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road
London
W1T 4TJ

View map

Email:
ctc.enquiries@ucl.ac.uk
Telephone:
+44 (0)20 7679 9898 (General CTC Enquiries)
Fax:
020 7679 9899

CTC staff

University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000